View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Valneva Provides Update on Recommendation for Use of Its Chikungunya V...

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities Saint Herblain (France), April 26, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ® for the prevention of disease caused by the chikungunya virus (CHIKV) following reports of serious adverse events (SAEs) in elderly people with comorbidities during the ongoing vaccination campaign in ...

 PRESS RELEASE

Valneva fait un point sur la recommandation d’utilisation de son vacci...

Valneva fait un point sur la recommandation d’utilisation de son vaccin contre le chikungunya par les autorités françaises Saint Herblain (France), le 26 avril 2025 – (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’autorité publique de santé en France, la Haute Autorité de Santé (HAS), a mis à jour sa recommandation concernant l'utilisation du vaccin à dose unique de Valneva, IXCHIQ®, pour la prévention de la maladie causée par le virus du chikungunya (CHIKV) suite à une notification d'effets indésirables graves chez des personnes â...

Aurelien Sivignon
  • Aurelien Sivignon
Carole Braudeau
  • Carole Braudeau

Credit Morning 04/22/2025

Verallia: awaiting Q1 results and BWGI takeover bid|Italian authorities impose restrictions on Unicredit as part of its bid for BPM|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 22/04/2025

Verallia : dans l’attente des résultats T1 et de l’offre de rachat par BWGI|Les autorités italiennes imposent des contraintes à Unicredit dans le cadre de son offre sur BPM|

Mahaut Arnaud ... (+3)
  • Mahaut Arnaud
  • Paul de Froment
  • Thomas Mordelle

Lhyfe: EUR149m subsidies confirmed for Green Horizon

Last Thursday during market hours, Lhyfe announced the confirmation of French State support for its 100MW Green Horizon project in Gonfreville-L'Orcher, close to Yara's ammonia facility near Le Havre (France). The public IPCEI support framework contract has been signed with BPI France for up to EUR

 PRESS RELEASE

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vac...

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers Saint Herblain (France), April 18, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ® for the prevention of disease caused by the chikungunya virus (CHIKV). ACIP maintained its current recommendation for IXCHI...

 PRESS RELEASE

Valneva fait le point sur la recommandation de l'ACIP pour les voyageu...

Valneva fait le point sur la recommandation de l'ACIP pour les voyageurs américains concernant son vaccin IXCHIQ® contre le chikungunya Saint-Herblain (France), le 18 avril 2025 – (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que lors de sa réunion ordinaire du 16 avril 2025, le comité consultatif américain sur les pratiques d'immunisation (ACIP) des centres de contrôle et de prévention des maladies (CDC) a mis à jour sa recommandation concernant l'utilisation du vaccin à dose unique de Valneva, IXCHIQ®, pour la prévention de la maladie...

Carole Braudeau
  • Carole Braudeau
IPS IPSOS
ATO ATOS SE ... (+5)

Credit Morning 04/17/2025

Forvia reassures with solid Q1 2025 revenue and new measures to address the current environment|Mahle aims to fully offset the direct impact of tariffs|

Carole Braudeau
  • Carole Braudeau
IPS IPSOS
ATO ATOS SE ... (+5)

Morning Crédit 17/04/2025

Forvia rassure avec un CA T1 2025 solide et de nouvelles mesures pour faire face à l’environnement actuel|Mahle vise à compenser intégralement l'impact direct des droits de douane|

Emmanuel Matot
  • Emmanuel Matot
Emmanuel Matot
  • Emmanuel Matot
 PRESS RELEASE

Ipsos: A first quarter in line with expectations in a volatile environ...

Ipsos: A first quarter in line with expectations in a volatile environment A first quarter in line with expectations in a volatile environment Paris, April 17, 2025 - , one of the world's leading market research companies, achieved a revenue of 568.5 million euros in the first quarter 2025. Growth stands at 2.0%, including -1.8% organic, 2.9% from scope effect, and 0.9% from favourable currency effects. Ben Page, CEO of Ipsos, stated: “The first quarter results are in line with our expectations, which anticipate a gradual recovery in activity over the year considering the comparison basis...

 PRESS RELEASE

Ipsos : Un 1er trimestre conforme aux attentes dans un environnement v...

Ipsos : Un 1er trimestre conforme aux attentes dans un environnement volatil Un 1er trimestre conforme aux attentes dans un environnement volatil Paris, 17 avril 2025 – , l’une des principales sociétés mondiales d’études de marché, a réalisé un chiffre d’affaires de 568,5 millions d’euros au premier trimestre 2025. La croissance s’établit à 2,0 %, dont -1,8 % en organique, 2,9 % d’effet de périmètre et 0,9% d’effets de change favorables. Ben Page, Directeur Général d’Ipsos, déclare : « Les résultats du premier trimestre sont en ligne avec nos attentes, qui tablent sur une reprise progres...

 PRESS RELEASE

Valneva to Participate in Multiple Events at the 25th World Vaccine Co...

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ® Saint-Herblain (France), April 16, 2025 – (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E. convention center in Washington, D.C. Under the leadership of the Company´s Chief Executive Officer, Thomas Lingelbach, a team of Valneva´s senior managers will participate in multiple events, including an impor...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch